Glaxo Wellcome.

PositionBrief Article

RESEARCH TRIANGLE PARK -- The U.S. Food and Drug Administration is investigating five deaths and other severe side effects among users of Lotronex, Glaxo Wellcome's new drug to treat irritable bowel syndrome. Glaxo says...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT